Compare Abeona Therapeutics Inc (ABEO) vs Altria Group Inc (MO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Altria Group Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Altria Group Inc trades at $64.97 (market cap $108.58B). The key difference: Altria Group Inc is far larger — about 257.8× Abeona Therapeutics Inc's market cap, and Altria Group Inc pays a 6.52% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | MO | |
|---|---|---|
Market Cap | $421.19M | $108.58B |
Sector | Health | Consumer Staples |
52-Week High | $7.45 | $74.92 |
52-Week Low | $4.17 | $54.72 |
Enterprise Value | $276.10M | $130.79B |
Dividend Yield | — | 6.52% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Altria Group Inc
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →
